Significance of the Wnt signaling pathway in coronary artery atherosclerosis
暂无分享,去创建一个
J. Tardif | É. Rhéaume | R. Cecere | S. Filimon | A. Schwertani | K. Khan | Bin Yu | H. Al-Kindi | Cristina Pop | Jacques Genest
[1] A. Poznyak,et al. Mechanisms of the Wnt Pathways as a Potential Target Pathway in Atherosclerosis , 2023, Journal of lipid and atherosclerosis.
[2] A. Poole,et al. Pro-inflammatory role of Wnt/β-catenin signaling in endothelial dysfunction , 2023, Frontiers in Cardiovascular Medicine.
[3] C. Antoniades,et al. Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications , 2022, Nature Reviews Cardiology.
[4] M. Silver,et al. Oxidized Low-Density Lipoprotein Induces WNT5A Signaling Activation in THP-1 Derived Macrophages and a Human Aortic Vascular Smooth Muscle Cell Line , 2020, Frontiers in Cardiovascular Medicine.
[5] A. Mani,et al. The role of Wnt signalling in development of coronary artery disease and its risk factors , 2020, Open Biology.
[6] J. Yamamoto-Furusho,et al. Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells. , 2020, Cellular signalling.
[7] C. Nguyên,et al. Convergence of Canonical and Non-canonical Wnt Signal: Differential Kat3 Coactivator Usage , 2019, Current molecular pharmacology.
[8] M. Bennett,et al. Vascular smooth muscle cells in atherosclerosis , 2019, Nature Reviews Cardiology.
[9] G. Angelini,et al. Aging differentially modulates the Wnt pro‐survival signalling pathways in vascular smooth muscle cells , 2018, Aging cell.
[10] M. Silver,et al. Blocking Wnt5a signaling decreases CD36 expression and foam cell formation in atherosclerosis. , 2018, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[11] D. Tousoulis,et al. Coronary versus carotid artery plaques. Similarities and differences regarding biomarkers morphology and prognosis , 2018, Current opinion in pharmacology.
[12] M. Montagnana,et al. Atherosclerosis Is an Inflammatory Disease which Lacks a Common Anti-inflammatory Therapy: How Human Genetics Can Help to This Issue. A Narrative Review , 2018, Front. Pharmacol..
[13] I. Albanese,et al. Atherosclerotic Calcification: Wnt Is the Hint , 2018, Journal of the American Heart Association.
[14] W. Matthijs Blankesteijn,et al. WNT Signaling in Cardiac and Vascular Disease , 2018, Pharmacological Reviews.
[15] H. Shimano,et al. SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology , 2017, Nature Reviews Endocrinology.
[16] A. Alsheikh-Ali,et al. MINI-FOCUS : AORTIC VALVE DISEASE Lipoprotein ( a ) Induces Human Aortic Valve Interstitial Cell Calci fi cation , 2017 .
[17] M. Kahn,et al. Wnt/β-catenin activation and macrophage induction during liver cancer development following steatosis , 2017, Oncogene.
[18] J. Tardif,et al. Role of Noncanonical Wnt Signaling Pathway in Human Aortic Valve Calcification , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[19] M. Boutros,et al. Wnt signaling in cancer , 2016, Oncogene.
[20] M. Bennett,et al. Vascular Smooth Muscle Cells in Atherosclerosis. , 2016, Circulation research.
[21] A. Orekhov,et al. Macrophage‐mediated cholesterol handling in atherosclerosis , 2015, Journal of cellular and molecular medicine.
[22] Laura S. Shankman,et al. KLF4 Dependent Phenotypic Modulation of SMCs Plays a Key Role in Atherosclerotic Plaque Pathogenesis , 2015, Nature Medicine.
[23] L. Badimón,et al. LRP5 deficiency down-regulates Wnt signalling and promotes aortic lipid infiltration in hypercholesterolaemic mice , 2015, Journal of cellular and molecular medicine.
[24] P. Bhatt,et al. Wnt5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders. , 2014, Atherosclerosis.
[25] Heiko Lemcke,et al. Ca2+-mediated Mitochondrial Reactive Oxygen Species Metabolism Augments Wnt/β-Catenin Pathway Activation to Facilitate Cell Differentiation* , 2014, The Journal of Biological Chemistry.
[26] D. Rader,et al. Apolipoprotein A-I and cholesterol efflux: the good, the bad, and the modified. , 2014, Circulation research.
[27] M. Sweet,et al. Recombinant Wnt3a and Wnt5a elicit macrophage cytokine production and tolerization to microbial stimulation via Toll‐like receptor 4 , 2014, European journal of immunology.
[28] S. Allahverdian,et al. Contribution of Intimal Smooth Muscle Cells to Cholesterol Accumulation and Macrophage-Like Cells in Human Atherosclerosis , 2014, Circulation.
[29] Wenwei Liu,et al. Wnt3a activates β1-integrin and regulates migration and adhesion of vascular smooth muscle cells. , 2014, Molecular medicine reports.
[30] G. Go,et al. The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue. , 2014, Cell metabolism.
[31] D. J. Goetz,et al. Wnt5a, TLR2 and TLR4 are elevated in advanced human atherosclerotic lesions , 2013, Inflammation Research.
[32] J. Moss,et al. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers , 2012, Cellular and Molecular Life Sciences.
[33] R. Nusse,et al. Wnt5a can both activate and repress Wnt/β-catenin signaling during mouse embryonic development. , 2012, Developmental biology.
[34] S. George,et al. Wnt signalling in smooth muscle cells and its role in cardiovascular disorders. , 2012, Cardiovascular research.
[35] G. Go,et al. Low-Density Lipoprotein Receptor (LDLR) Family Orchestrates Cholesterol Homeostasis , 2012, The Yale journal of biology and medicine.
[36] C. Yabe-Nishimura,et al. A crucial role for Nox 1 in redox‐dependent regulation of Wnt‐β‐catenin signaling , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] L. Badimón,et al. Wnt pathway activation, cell migration, and lipid uptake is regulated by low-density lipoprotein receptor-related protein 5 in human macrophages. , 2011, European heart journal.
[38] Matthias Nahrendorf,et al. Molecular Imaging of Coronary Atherosclerosis and Myocardial Infarction: Considerations for the Bench and Perspectives for the Clinic , 2011, Circulation research.
[39] F. Salvi,et al. Carotid artery atherosclerosis in hypertensive patients with a functional LDL receptor-related protein 6 gene variant. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[40] Michael Kühl,et al. The Multiple Phases and Faces of Wnt Signaling During Cardiac Differentiation and Development , 2010, Circulation research.
[41] D. W. Kim,et al. Wnt5a Induces Endothelial Inflammation via β-Catenin–Independent Signaling , 2010, The Journal of Immunology.
[42] D. J. Goetz,et al. Wnt5a is expressed in murine and human atherosclerotic lesions. , 2008, American journal of physiology. Heart and circulatory physiology.
[43] J. Malmquist,et al. Regulation of In Vitro Vascular Calcification by BMP4, VEGF and Wnt3a , 2007, Calcified Tissue International.
[44] K. Griendling,et al. Reactive oxygen species signaling in vascular smooth muscle cells. , 2006, Cardiovascular research.
[45] J. Genest,et al. Cellular cholesterol homeostasis in vascular endothelial cells. , 2006, The Canadian journal of cardiology.
[46] L. Topol,et al. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation , 2003, Development.
[47] Darwin J. Prockop,et al. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[48] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[49] A. Giaid,et al. Endothelial expression of endothelial nitric oxide synthase and endothelin-1 in human coronary artery disease. Specific reference to underlying lesion. , 1999, Laboratory investigation; a journal of technical methods and pathology.